Challenges in CLL: Fixed duration therapies: where do they fit?

On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

In light of recent data updates, Professor Paolo Ghia and Professor Peter Hillmen will discuss the potential role of fixed duration therapies in the management of CLL. In particular they will:

•    Consider which patients with CLL may benefit from a fixed duration approach
•    Assess when fixed duration therapies should best be incorporated into the treatment algorithm
•    With a look to the future, evaluate the fixed duration regimens that are currently being investigated for the treatment of CLL.

During the live broadcast you will have the opportunity to ask questions and interact with the faculty.

Please REGISTER now for the live broadcast and to enable access to the on-demand version.

Learning objective:

After participating in this broadcast you should be able to:

• Discuss the role of fixed duration therapies in the management of patients with CLL

Faculty:

• Paolo Ghia (Italy)
• Peter Hillmen (UK)
• Catherine Hood (UK, moderator)